CA-SYSDIG
7.3.2024 16:01:30 CET | Business Wire | Press release
Sysdig, the leader in cloud security powered by runtime insights, today announced that the company was named a Strong Performer — one of only two vendors to receive the recognition — in Gartner Peer Insights “Voice of the Customer” for Cloud Security Posture Management (CSPM) Tools. Sysdig is the only cloud security platform to receive the maximum of five stars in the report, which was derived directly from verified customer feedback, and synthesizes reviews and ratings received as of November 30, 2023.
In addition to receiving the highest overall rating, Sysdig received top marks in each category:
- Product Capabilities: 4.9/5
- Sales Experience: 4.9/5
- Deployment Experience: 4.9/5
- Support Experience: 5/5
As the cloud landscape continues to evolve, Sysdig is at the forefront of cloud security innovation, offering active cloud risk prioritization, vulnerability management, and compliance solutions that go beyond traditional static checks. The company's dedication to providing comprehensive visibility and robust security measures has garnered widespread acclaim from its user base, as it believes is evidenced by its exceptional ratings in the Gartner “Voice of the Customer” report.
"Customers demand and deserve excellence, and we are thrilled to receive such high praise in the Gartner Voice of the Customer report. We believe a 5 out of 5 rating underscores our commitment to CISOs and boards to keep their cloud environment safe," said Knox Anderson, SVP of Product Management at Sysdig. "The industry knows Sysdig as the leader in CNAPP, and now they can feel confident knowing how much our customers love our CSPM solution."
Read the full “Voice of the Customer” report for Cloud Security Posture Management Tools.
Sysdig Customers Praise Productivity Driven by Runtime Insights
The cloud is a dynamic environment where new risks and threats can appear at any time. Most CSPM solutions perform periodic scanning, which only shows static risk and leaves visibility gaps for attackers to exploit. Sysdig empowers organizations to strengthen their cloud security posture through unified findings with active risk prioritization, agentless scanning, attack path analysis, inventory, and real-time security posture checks. Using runtime insights, Sysdig offers unparalleled visibility into active cloud risk, such as real-time configuration changes, suspicious user activity, in-use permission and packages, and workload threats.
By prioritizing active cloud risk, security teams can work more productively by reducing alert fatigue and focusing on addressing the most imminent active threats in their cloud environment. In essence, Sysdig strengthens organizations’ approaches to cloud security posture management, from risk prioritization and vulnerability management to proactive threat detection and compliance, giving them peace of mind that their assets are protected when cloud attacks can happen in a matter of minutes.
Customer feedback highlighted Sysdig's unique approach to CSPM, with users praising the platform for its comprehensive cloud-native security features and ability to improve incident response times. But CSPM is only one part of the Sysdig cloud-native application protection platform (CNAPP), which combines CSPM with cloud workload protection, cloud infrastructure entitlement management, and detection and response in a single security platform to provide customers with end-to-end coverage, from prevention to defense. With Sysdig, organizations can mitigate security issues fast, bolster operational efficiency across multi-cloud environments, and protect the entire software development life cycle.
What our Customers are Saying in Gartner Peer Insights
“I’m genuinely impressed with the level of real-time security posture checks [Sysdig] brings to our cloud infrastructure. The solution has proven to be an invaluable asset in ensuring the safety of our cloud-native application and data.” [Read the full review here]
- Director of Strategic Initiatives; Software Company
“Sysdig CSPM provides unmatched insight and fortified security for cloud-native infrastructure with state-of-art technology. Powered by Falco, it offers comprehensive visibility, empowering businesses to monitor and safeguard cloud assets efficiently…” [Read the full review here]
- VP, IT Security and Risk Management; Financial Company
“Our adoption of Sysdig CSPM was fueled by the growing complexity of our cloud environment. As our presence expanded rapidly, robust security and compliance became imperative. We required a unified solution that could monitor, detect, and manage risk across both AWS and GCP.” [Read the full review here]
- Director of Strategic Initiatives; Software Company
“Since implementing Sysdig CSPM, our incident response time has drastically improved, allowing us to mitigate security issues promptly.” [Read the full review here]
- Information Security Officer; IT Services Company
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product, or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, PEER INSIGHTS is a registered trademark of Gartner, Inc. and/or its affiliates and both are used herein with permission. All rights reserved.
This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available here.
Resources
- Visit Sysdig’s page on Gartner Peer Insights.
- Read Sysdig's blog, “Customers Rate Sysdig 5 Out of 5 in Gartner ‘Voice of the Customer’ for Cloud Security Posture Management Tools” to learn more about the announcement.
- Watch “Sysdig. Secure Every Second.” to learn more about the company.
About Sysdig
In the cloud, every second counts. Attacks move at warp speed, and security teams must protect the business without slowing it down. Sysdig stops cloud attacks in real time, instantly detecting changes in risk with runtime insights and open source Falco. Sysdig correlates signals across cloud workloads, identities, and services to uncover hidden attack paths and prioritize real risk. From prevention to defense, Sysdig helps enterprises focus on what matters: innovation. Sysdig. Secure Every Second.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240307640009/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
